Psychotropic drugs and fatal pulmonary embolism: a comment

F. Curtin,P. Schulz

DOI: https://doi.org/10.1002/pds.958

2004-09-01

Pharmacoepidemiology and Drug Safety

Abstract:Parkin et al . 1 have reported the results of a nation-wide case-control study on the association between the use of psychotropic drugs and fatal pulmonary embolism. This important study is comprehensive, including all cases reported in New Zealand between 1990 and 1998. The main results were that antipsychotics and antidepressants were associated with the risk of fatal pulmonary embolism in a statistically significant way, while other psychotropic drugs did not show a statistically significant association. These results are in line with the results from a case-control study and an autopsy series of patients receiving anti-psychotics, 2 those from a case-control study on in patients receiving conventional antipsychotics 3 or from a case series of patients with clozapine. 4 However, the association between thromboembolism and antipsychotics or antidepressants has not been foundsystematically.Ray etal . 5 foundinaretrospective study of patients over 65years of age that antipsychotics and antidepressants did not increase the risk of deep venous thrombosis or pulmonary embolism. There are confounding factors which remain to be accounted for. It cannot be excluded that certain conditions, for which antipsychotics or antidepressants are used, are predisposing factors for venous thrombosis and pulmonary embolism. Catatonia is a form of schizophrenia in which patients are at higher risk of venous thrombosis due to the absence or limitation of spontaneous movements. 6 Similarly severe decrease in spontaneous movements can be found in severe form major depression and could be a risk factor for deep vein thrombosis and pulmonary embolism.